Invesco Ltd. - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Invesco Ltd. ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$76,150,000
-30.7%
41,769,000
-8.1%
0.03%
-34.1%
Q3 2014$109,884,000
+20.1%
45,430,000
-2.6%
0.04%
+22.2%
Q2 2014$91,527,000
+16.4%
46,623,000
+0.2%
0.04%
+12.5%
Q1 2014$78,660,000
+15.6%
46,527,000
+1.9%
0.03%
+18.5%
Q4 2013$68,041,000
+22.1%
45,646,000
+0.5%
0.03%
+12.5%
Q3 2013$55,705,000
+2.9%
45,404,000
+0.1%
0.02%
-4.0%
Q2 2013$54,115,00045,356,0000.02%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GRACE BROTHERS MANAGEMENT LLC 2,500,000$4,916,0004.33%
SYMPHONY ASSET MANAGEMENT LLC 19,840,000$38,948,0004.05%
SILVERBACK ASSET MANAGEMENT LLC 19,709,000$38,695,0004.00%
MACKAY SHIELDS LLC 31,471,000$61,916,0003.41%
Sage Capital Management, LLC 1,500,000$2,942,0002.98%
ALTEGRIS ADVISORS, L.L.C. 250,000$491,0002.56%
Wellesley Asset Management 16,220$31,923,0002.01%
GUARDIAN LIFE INSURANCE CO OF AMERICA 8,600,000$16,883,0001.62%
CAMDEN ASSET MANAGEMENT L P /CA 13,862,000$27,213,0001.58%
Calamos Wealth Management LLC 2,061,000$4,045,0001.15%
View complete list of SALIX PHARMACEUTICALS INC shareholders